Cargando…

Aminopeptidase N inhibition: potential SARS therapy

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149161/
http://dx.doi.org/10.2165/00128413-200313860-00002
_version_ 1783520751280717824
collection PubMed
description
format Online
Article
Text
id pubmed-7149161
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-71491612020-04-13 Aminopeptidase N inhibition: potential SARS therapy Inpharma Weekly Review Springer International Publishing 2013-02-09 2003 /pmc/articles/PMC7149161/ http://dx.doi.org/10.2165/00128413-200313860-00002 Text en © Adis International Ltd 2003 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review
Aminopeptidase N inhibition: potential SARS therapy
title Aminopeptidase N inhibition: potential SARS therapy
title_full Aminopeptidase N inhibition: potential SARS therapy
title_fullStr Aminopeptidase N inhibition: potential SARS therapy
title_full_unstemmed Aminopeptidase N inhibition: potential SARS therapy
title_short Aminopeptidase N inhibition: potential SARS therapy
title_sort aminopeptidase n inhibition: potential sars therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149161/
http://dx.doi.org/10.2165/00128413-200313860-00002